China's COVID-19 vaccine developer Clover raises $240m in HK IPO

China's COVID-19 vaccine developer Clover raises $240m in HK IPO

Chinese COVID19 vaccine developer Clover Biopharmaceuticals said on Thursday it raised $240 million in net proceeds in an initial public offering (IPO) of shares in Hong Kong.